Donate

News

Latest news

Pharmac widens funding for lenalidomide for those with blood cancer

April 2, 2020

An open letter to the Prime Minister of New Zealand, Jacinda Ardern

April 1, 2020

Covid 19 coronavirus: Pharmac eases restrictions on cancer drugs during Covid-19 pandemic

April 1, 2020

Kiwis with incurable blood cancer set to receive newly reimbursed treatment option

April 1, 2020

New drug could reverse treatment resistance in advanced multiple myeloma

March 30, 2020

Article of the week: Managing haematology and oncology patients during the COVID-19 pandemic

March 25, 2020,

Information About COVID-19 for Myeloma Patients

March 23, 2020

Coronavirus in NZ: How to self-isolate – Kiwi diagnosed with cancer shares advice

March 18, 2020

National Research Cancer Institute UK Confirms Benefit Molecular Profiling in Multiple Myeloma

March 18, 2020

Myeloma and the Coronavirus

March 9, 2020

Multiple Myeloma Research Review

February 26, 2020

New CAR T-cell Therapy Shows Early Promise Against Multiple Myeloma in Lab Study

February 25, 2020

Organ responses with daratumumab therapy in previously treated AL amyloidosis

February 17, 2020

Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy

January 28, 2020

ALCYONE Update: Adding Daratumumab to VMP Improves Survival in Transplant-Ineligible Myeloma

January 23, 2020

Cancer drug funding welcomed

January 17, 2020

Newsletter: January 2020

January 16, 2020

Myeloma NZ calls on Pharmac to make good on access deal

January 14, 2020

Pharmac to widen treatment access for myeloma – New Zealand’s second most common blood cancer

December 20, 2019

Multiple Myeloma Research Review

December 12, 2019

Drug Previously Thought to Treat Alzheimer Shows Potential in Multiple Myeloma

December 5, 2019

Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’

December 3, 2019

Major developments in multiple myeloma to be presented at ASH

December 3, 2019

Myeloma Medicines Applications: The status of medicines applications for myeloma currently with Pharmac

December 2, 2019

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis

November 21, 2019

Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget

November 18, 2019

FDA Approves Daratumumab-Based Quadruplet Regimen for Transplant-Eligible Myeloma

November 18, 2019

Submission on the draft Cancer Action Plan 2019-2029

November 15, 2019

Prophylactic antibiotics could benefit patients with newly diagnosed myeloma

November 11, 2019

Funding Medicines in New Zealand: Revision of the Medicines waiting list to 30 June 2019

November 5, 2019

Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand

November 5, 2019,

In pursuit of improved outcomes in high-risk multiple myeloma 

November 1, 2019

Health Select Committee hearing alert: Pharmac responds to our petition

October 21, 2019,

Concern proposed bill may make cancer medication unaffordable for Kiwis

October 7, 2019

Wake-up call for cancer agency boss Diana Sarfati

October 4, 2019

Newsletter: October 2019

October 1, 2019,

Major biological processes involved in the development of myeloma uncovered

September 18, 2019

Real-World Insight on Patients With Multiple Myeloma: Results Drawn From a Large Health Plan

September 17, 2019

New Therapies for Blood Cancers Hold Promise

September 12, 2019

Reducing the Risk of Blood Clots in Patients With Multiple Myeloma

September 10, 2019

Myeloma Seminar for Patients, Families and Friends

September 9, 2019,

Emerging Treatments for Patients with Myeloma Prove Promising Despite Obstacles

September 9, 2019

Government unveils national cancer agency and $60 million injection into Pharmac

September 2, 2019

Blood cancer more likely to affect relatives of people who have it, study shows

August 30, 2019

Multiple Myeloma Research Review

August 29, 2019

Suboptimal Implementation of Supportive Care in Older Patients With Multiple Myeloma

August 28, 2019

Another myeloma drug with same target as CAR-Ts shows successful Phase II results

August 26, 2019

Dual CAR T-cell combination a ‘promising treatment option’ for multiple myeloma

August 21, 2019

Government urged to expand Pharmac’s drug budget after barrage of emotional pleas from sufferers

August 9, 2019

Health Select Committee hears pleas from survivors and sufferers

August 8, 2019